SC
KYTH

Steven Cohen’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Steven Cohen’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-15,200
Closed -$583K – 860
2014
Q2 		$583K Buy
+15,200
New +$531K ﹤0.01% 635

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Steven Cohen's KYTH Position: Q3 2014 in Review

Steven Cohen sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2014, closing a stake of 15,200 shares — an estimated $583K sold.

Steven Cohen first reported a position in KYTH in Q2 2014 and held it in 1 quarter. The position peaked at $583K in Q2 2014. 110 funds tracked by Wall St. Rank hold KYTH as of Q3 2014.

  • Steven Cohen reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2014 after selling out during the quarter.
  • Steven Cohen sold 15,200 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2014, an estimated $583K.
  • Steven Cohen first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2014 and held it in 1 quarter.
  • Steven Cohen's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $583K in Q2 2014.
  • 110 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2014.

Based on Point72 Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.